Narrow search
Showing 1 - 10 of 642,069
Cover Image
Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany
Damm, Oliver; Eichner, Martin; Rose, Markus Andreas; … - In: The European journal of health economics : HEPAC ; … 16 (2015) 5, pp. 471-488
Persistent link: https://www.econbiz.de/10011299236
Cover Image
Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany
Kuhlmann, Alexander; Schulenburg, Johann-Matthias von der - In: The European journal of health economics : HEPAC ; … 18 (2017) 3, pp. 273-292
Persistent link: https://www.econbiz.de/10011868215
Cover Image
Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting : the case of Thailand at start of the pandemic
Wang, Yi; Nantasit Luangasanatip; Wirichada Pan–ngum; … - In: The European journal of health economics 24 (2023) 5, pp. 735-748
Persistent link: https://www.econbiz.de/10014328090
Cover Image
A systematic review of pharmacoeconomic evaluations of erlotinib in the first-line treatment of advanced non-small cell lung cancer
Nguyen Cuc Thi Thu; Petrelli, Fabio; Scuri, Stefania; … - In: The European journal of health economics : HEPAC ; … 20 (2019) 5, pp. 763-777
Persistent link: https://www.econbiz.de/10012061274
Cover Image
Value appropriation in hepatitis C
Lindgren, Peter; Löfvendahl, Sofia; Brådvik, Gunnar; … - In: The European journal of health economics 23 (2022) 6, pp. 1059-1070
Persistent link: https://www.econbiz.de/10013407066
Cover Image
Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic
Lugnér, Anna K.; Mylius, Sido D.; Wallinga, Jacco - In: Health economics 19 (2010) 5, pp. 518-531
Persistent link: https://www.econbiz.de/10008650435
Cover Image
Comment on "Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany"
Gandjour, Afschin - In: The European journal of health economics : HEPAC ; … 19 (2018) 3, pp. 471-472
Persistent link: https://www.econbiz.de/10011952176
Cover Image
Authors' reply to Gandjour: "Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany"
Kuhlmann, Alexander; Schulenburg, Johann-Matthias von der - In: The European journal of health economics : HEPAC ; … 19 (2018) 3, pp. 473-481
Persistent link: https://www.econbiz.de/10011952179
Cover Image
Country versus pharmaceutical company interests for hepatitis C treatment
Lothan, Roy; Gutman, Noa; Yamin, Dan - In: Health care management science : a new journal serving … 25 (2022) 4, pp. 725-749
Persistent link: https://www.econbiz.de/10013483722
Cover Image
Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model
Schobert, Deniz; Remy, Vanessa; Schoeffski, Oliver - In: Health economics review 2 (2012) 19, pp. 1-10
Introduction: Persistent infections with human papillomavirus (HPV) are a necessary cause of cervical cancer and are responsible for important morbidity in men and women. Since 2007, HPV vaccination has been recommended and funded for all girls aged 12 to 17 in Germany. A previously published...
Persistent link: https://www.econbiz.de/10009752876